| Symbol |
Name |
|
ABLIM1
|
actin binding LIM protein 1
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast)
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCY4
|
adenylate cyclase 4
|
|
ADCY7
|
adenylate cyclase 7
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADCY9
|
adenylate cyclase 9
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AES
|
amino-terminal enhancer of split
|
|
AHNAK
|
AHNAK nucleoprotein
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
AMOT
|
angiomotin
|
|
ANAPC1
|
anaphase promoting complex subunit 1
|
|
ANAPC11
|
anaphase promoting complex subunit 11
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANXA8
|
annexin A8
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
|
ARF4
|
ADP-ribosylation factor 4
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28
|
|
ARL4A
|
ADP-ribosylation factor-like 4A
|
|
ARL6
|
ADP-ribosylation factor-like 6
|
|
ARRB1
|
arrestin, beta 1
|
|
ATF6
|
activating transcription factor 6
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
AVPI1
|
arginine vasopressin-induced 1
|
|
BCAP29
|
B-cell receptor-associated protein 29
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BEX4
|
brain expressed, X-linked 4
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BNIP2
|
BCL2/adenovirus E1B 19kDa interacting protein 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C3AR1
|
complement component 3a receptor 1
|
|
CA8
|
carbonic anhydrase VIII
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCND1
|
cyclin D1
|
|
CCNJ
|
cyclin J
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD93
|
CD93 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC23
|
cell division cycle 23
|
|
CDC42SE1
|
CDC42 small effector 1
|
|
CDCA7
|
cell division cycle associated 7
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CELSR1
|
cadherin, EGF LAG seven-pass G-type receptor 1
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CFD
|
complement factor D (adipsin)
|
|
CFH
|
complement factor H
|
|
CHAF1B
|
chromatin assembly factor 1, subunit B (p60)
|
|
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle)
|
|
CHST2
|
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
|
CIDEC
|
cell death-inducing DFFA-like effector c
|
|
CKS2
|
CDC28 protein kinase regulatory subunit 2
|
|
CLDN5
|
claudin 5
|
|
CLIC3
|
chloride intracellular channel 3
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
|
CLU
|
clusterin
|
|
CMTM6
|
CKLF-like MARVEL transmembrane domain containing 6
|
|
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8
|
|
CNTN1
|
contactin 1
|
|
COL13A1
|
collagen, type XIII, alpha 1
|
|
COL15A1
|
collagen, type XV, alpha 1
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
CPXM1
|
carboxypeptidase X (M14 family), member 1
|
|
CR1L
|
complement component (3b/4b) receptor 1-like
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
CRB3
|
crumbs family member 3
|
|
CRCP
|
CGRP receptor component
|
|
CRIP2
|
cysteine-rich protein 2
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CTGF
|
connective tissue growth factor
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CYTH3
|
cytohesin 3
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAD1
|
defender against cell death 1
|
|
DAP
|
death-associated protein
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX41
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHH
|
desert hedgehog
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DPF2
|
D4, zinc and double PHD fingers family 2
|
|
DPT
|
dermatopontin
|
|
DSG2
|
desmoglein 2
|
|
DTX1
|
deltex 1, E3 ubiquitin ligase
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDN1
|
endothelin 1
|
|
EFNB1
|
ephrin-B1
|
|
EFS
|
embryonal Fyn-associated substrate
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2)
|
|
EMP1
|
epithelial membrane protein 1
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENG
|
endoglin
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA4
|
EPH receptor A4
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
EREG
|
epiregulin
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAS
|
Fas cell surface death receptor
|
|
FBLN2
|
fibulin 2
|
|
FBXW2
|
F-box and WD repeat domain containing 2
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FECH
|
ferrochelatase
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FERMT2
|
fermitin family member 2
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXJ1
|
forkhead box J1
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD4
|
frizzled class receptor 4
|
|
G0S2
|
G0/G1 switch 2
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAP43
|
growth associated protein 43
|
|
GAS8
|
growth arrest-specific 8
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GGT5
|
gamma-glutamyltransferase 5
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA4
|
gap junction protein, alpha 4, 37kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
|
GJC1
|
gap junction protein, gamma 1, 45kDa
|
|
GLCE
|
glucuronic acid epimerase
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNAS-AS1
|
GNAS antisense RNA 1
|
|
GNB5
|
guanine nucleotide binding protein (G protein), beta 5
|
|
GNG11
|
guanine nucleotide binding protein (G protein), gamma 11
|
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP5
|
glycoprotein V (platelet)
|
|
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPR182
|
G protein-coupled receptor 182
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GSPT2
|
G1 to S phase transition 2
|
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HMGB3
|
high mobility group box 3
|
|
HOMER3
|
homer scaffolding protein 3
|
|
HP
|
haptoglobin
|
|
HSPA2
|
heat shock 70kDa protein 2
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFI30
|
interferon, gamma-inducible protein 30
|
|
IFI35
|
interferon-induced protein 35
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFRD2
|
interferon-related developmental regulator 2
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL11RA
|
interleukin 11 receptor, alpha
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7R
|
interleukin 7 receptor
|
|
ILK
|
integrin-linked kinase
|
|
INCENP
|
inner centromere protein antigens 135/155kDa
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB5
|
integrin, beta 5
|
|
ITPKB
|
inositol-trisphosphate 3-kinase B
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1522
|
KIAA1522
|
|
KIFAP3
|
kinesin-associated protein 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF6
|
Kruppel-like factor 6
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT8
|
keratin 8, type II
|
|
LAMA2
|
laminin, alpha 2
|
|
LAMA4
|
laminin, alpha 4
|
|
LAMB1
|
laminin, beta 1
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LEPR
|
leptin receptor
|
|
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
LYZ
|
lysozyme
|
|
MACF1
|
microtubule-actin crosslinking factor 1
|
|
MAFK
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K6
|
mitogen-activated protein kinase kinase kinase 6
|
|
MAPRE1
|
microtubule-associated protein, RP/EB family, member 1
|
|
MBP
|
myelin basic protein
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MNAT1
|
MNAT CDK-activating kinase assembly factor 1
|
|
MPDZ
|
multiple PDZ domain protein
|
|
MRAS
|
muscle RAS oncogene homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
MYDGF
|
myeloid-derived growth factor
|
|
MYO6
|
myosin VI
|
|
MYO7A
|
myosin VIIA
|
|
NAALAD2
|
N-acetylated alpha-linked acidic dipeptidase 2
|
|
NAT6
|
N-acetyltransferase 6 (GCN5-related)
|
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKIRAS1
|
NFKB inhibitor interacting Ras-like 1
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6
|
|
NRBP1
|
nuclear receptor binding protein 1
|
|
NRGN
|
neurogranin (protein kinase C substrate, RC3)
|
|
NT5DC2
|
5'-nucleotidase domain containing 2
|
|
NUMB
|
numb homolog (Drosophila)
|
|
OGFR
|
opioid growth factor receptor
|
|
OMD
|
osteomodulin
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
PALM
|
paralemmin
|
|
PAQR7
|
progestin and adipoQ receptor family member VII
|
|
PCDHA1
|
protocadherin alpha 1
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PDE7A
|
phosphodiesterase 7A
|
|
PDE8A
|
phosphodiesterase 8A
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDLIM3
|
PDZ and LIM domain 3
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PGAP2
|
post-GPI attachment to proteins 2
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP4
|
plakophilin 4
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLAA
|
phospholipase A2-activating protein
|
|
PLP1
|
proteolipid protein 1
|
|
PMP22
|
peripheral myelin protein 22
|
|
PON1
|
paraoxonase 1
|
|
PPAP2A
|
phosphatidic acid phosphatase type 2A
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCH
|
protein kinase C, eta
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTPRF
|
protein tyrosine phosphatase, receptor type, F
|
|
PTPRU
|
protein tyrosine phosphatase, receptor type, U
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PVR
|
poliovirus receptor
|
|
QARS
|
glutaminyl-tRNA synthetase
|
|
RAB12
|
RAB12, member RAS oncogene family
|
|
RAB20
|
RAB20, member RAS oncogene family
|
|
RAB23
|
RAB23, member RAS oncogene family
|
|
RAB28
|
RAB28, member RAS oncogene family
|
|
RAB34
|
RAB34, member RAS oncogene family
|
|
RAB6A
|
RAB6A, member RAS oncogene family
|
|
RAB9A
|
RAB9A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELN
|
reelin
|
|
RGS10
|
regulator of G-protein signaling 10
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHOB
|
ras homolog family member B
|
|
RHOD
|
ras homolog family member D
|
|
RHOQ
|
ras homolog family member Q
|
|
RHOU
|
ras homolog family member U
|
|
RIT1
|
Ras-like without CAAX 1
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROGDI
|
rogdi homolog (Drosophila)
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RSU1
|
Ras suppressor protein 1
|
|
RTKN
|
rhotekin
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
S1PR4
|
sphingosine-1-phosphate receptor 4
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SESN1
|
sestrin 1
|
|
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated)
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIVA1
|
SIVA1, apoptosis-inducing factor
|
|
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2
|
|
SMAD6
|
SMAD family member 6
|
|
SMAD7
|
SMAD family member 7
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMC4
|
structural maintenance of chromosomes 4
|
|
SNAPIN
|
SNAP-associated protein
|
|
SNORD95
|
small nucleolar RNA, C/D box 95
|
|
SNX2
|
sorting nexin 2
|
|
SNX4
|
sorting nexin 4
|
|
SORBS3
|
sorbin and SH3 domain containing 3
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
SSPN
|
sarcospan
|
|
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein
|
|
STAB1
|
stabilin 1
|
|
STMN2
|
stathmin 2
|
|
STRBP
|
spermatid perinuclear RNA binding protein
|
|
SYNJ2BP
|
synaptojanin 2 binding protein
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TBX2
|
T-box 2
|
|
TBX3
|
T-box 3
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THBD
|
thrombomodulin
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TLE3
|
transducin-like enhancer of split 3
|
|
TMEM11
|
transmembrane protein 11
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNS2
|
tensin 2
|
|
TNXB
|
tenascin XB
|
|
TOLLIP
|
toll interacting protein
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRDMT1
|
tRNA aspartic acid methyltransferase 1
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
UNC119
|
unc-119 homolog (C. elegans)
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
VAMP2
|
vesicle-associated membrane protein 2 (synaptobrevin 2)
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAN
|
versican
|
|
VCL
|
vinculin
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WDR1
|
WD repeat domain 1
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
ZMAT3
|
zinc finger, matrin-type 3
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
|
ZNF106
|
zinc finger protein 106
|